NON-SPECIFIC ESTERASE ACTIVITY
Non-specific esterase activity was assessed using ot-naphthyl acetate as described previously."2 When assessment of non-specific esterase activity was combined with assessment of UDPGD activity or immunochemistry, assessment of non-specific esterase activity was performed last.
IMMUNOCHEMISTRY
The following monoclonal antibodies were used for the characterisation of synovial intimal and nodule palisading cells: EBM 11 (anti-CD68) for macrophages'3 at 1/200 (DAKO); 5B5 (anti-prolyl hydroxylase) for fibroblasts'5 at 1/50 (DAKO), 1 4C3 for VCAM-1,16 HP2/ 1 for the cx4 integrin chain"7 at 1/200 (Serotec), and B-D15 for the (31 integrin chain'8 at 1/50 (Serotec). In addition, the following antibodies were used to identify other leucocyte populations: UCHT1 (anti-CD3) for T lymphocytes (DAKO), 4KB 128 (anti-CD22) for B lymphocytes, and NP57 (antineutrophil) elastase for neutrophils. Antibodies were used in either native form or biotinylated for double labelling. Binding of monoclonal antibodies was visualised using either goat antimouse IgG/fluorescein isothiocyanate (FITC) (Sera Lab) at 1/20 in PBS plus 20% normal human serum (NHS) or, for biotinylated monoclonal antibodies, streptavidin/tetramethyl rhodamine isothiocyanate (TRITC) (Sera Lab) at 1/20 in PBS plus 20% NHS, or, for permanent enzymatic preparations, rabbit antimouse immunoglobulins (DAKO) 1/20 in TRIS buffered saline (TBS) plus 20% NHS and alkaline phosphatase antialkaline phosphatase (DAKO) at 1/50 in TBS plus 20% NHS.
Sections were incubated with primary reagents for one hour at room temperature, and all subsequent incubations were for 30 minutes. Incubations for immunofluorescence were in PBS at pH 7-6, and for the alkaline phosphatase-antialkaline phosphatase (APAAP) technique in TBS at pH [7] [8] 
Results

SYNOVIAL TISSUES
Findings on normal and diseased synovial tissues were in keeping with those previously published.9 10 19 By a series of double labelling experiments it was shown that normal synovial intimal cells could be divided into (a) macrophages positive for CD68 or nonspecific esterase and (b) synoviocytes of high UDPGD activity, VCAM-1 expression, and prolyl hydroxylase content. The proportions of the two cell types varied from place to place within samples and between samples. In normal and osteoarthritic tissues the ratio of mean UDPGD activity in synoviocytes to that in subintimal cells, assessed by microdensitometry, was consistently greater than 4:1 (highest value 9:1). In rheumatoid synovial tissues levels of UDPGD activity in intimal cells tended to be lower with activity ratios (synoviocyte: subintimal cell) of 2-5:1 or less.
The The exception to this rule was a sample in which the necrobiotic centre had split away from the surrounding tissue in places to produce a well defined cleft partially surrounding a necrotic mass. In this instance the tissue surrounding the cleft was lined by a layer of cells indistinguishable from synovial intima, containing a mixture of (a) CD68 positive macrophages and (b) CD68 negative cells of high UDPGD activity, which stained for VCAM-1 and prolyl hydroxylase (figs 4 and 5). This cleft did not communicate with spaces outside the individual necrobiotic focus and did not represent a pre-existing bursa.
As in synovium, the (x4 integrin chain was seen on macrophages and lymphocytes generally, with no preferential staining of the palisading layer. In contrast with synovium, staining for 1 integrin was generally weak, with no preferential staining of the palisading layer.
Lymphocytes were present in small clusters peripheral to but not within the palisading layer. Neutrophils were present close to blood vessels, between these vessels and the palisading layer in small numbers, occasionally within the palisading layer itself, and in larger numbers within the necrotic zone, central to the palisading layer. Discussion A number of workers have shown that the palisading layer of rheumatoid nodules and of synovial intima include cells carrying markers of mature macrophages.2" The findings of this study suggest that although the palisading layer also includes fibroblasts, as in synovial intima, the fibroblasts lack the features of synoviocytes. Preferential staining for the I 1 integrin chain has been reported previously in synovial intima.20 The present double labelling studies suggest that the preferential staining in the intima is due to the presence of the , 1 chain on synoviocyte membranes, chiefly on processes on the luminal side of the cells. In the absence of staining for the (4 chain it is likely that the I1 chain on synoviocytes is present in the form of VLA-5. The ,1 1 integrin chain does not appear to be present on either type of cell in the palisading layer of nodules. We have confirmed that macrophages of the palisading layer share the prominent non-specific esterase activity of synovial intimal macrophages.
The appearance of VCAM-1 and high UDPGD activity on cells lining a cleft within an area of necrobiosis would seem to be a late secondary event, probably of no significance to the genesis of the original lesion. VCAM-1 expression and UDPGD activity have also been found in cells on the surface of regenerated synovial tissue taken from around an artificial joint prosthesis.2" Evidence is accumulating that fibroblastic cells will only take on these properties when present on connective tissue surfaces exposed to shearing stresses.22 This may be relevant to the absence of synoviocytes from the palisading layer itself. Nevertheless, as nodules characteristically form at sites of mechanical stress, shearing forces may well be experienced by cells on the surface of clefts at the lesion centre.
It has been suggested that the cellular events in synovitis and the rheumatoid nodule are essentially the same. Infiltrating lymphocytes appear to remain largely on the vascular side of the macrophage/fibroblast layer where they may form clusters. Neutrophils appear to migrate rapidly through this layer so that they are found at greatest density either in synovial fluid or in the necrotic centre of the nodule. The synovial intima and the palisading layer could be seen as having a similar role in perpetuating the local inflammatory process via the generation of chemotactic gradients, angiogenic factors, and other mediators. The findings of this study do not alter this possibility, but it appears that the specialised nature of synoviocytes is not critical to any cooperative role they might have with the associated macrophages in disease. The expression of VCAM-1 in particular does not appear to be essential to such a role in the nodule, though it remains possible that VCAM-1 expression in synovium facilitates interactions, thereby making the joint more susceptible to inflammation in the presence of a systemic immunological disturbance, with almost 100% of rheumatoid patients having joint disease and only 20% having subcutaneous nodules. 
